GE-267
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GE-267, covering 2025-03-25 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease